» Articles » PMID: 31180388

Ectopic Cushing's Syndrome Due to Adrenocorticotropic Hormone Secreting Atypical Thymic Carcinoid Tumor

Overview
Publisher Kare Publishing
Specialty General Medicine
Date 2019 Jun 11
PMID 31180388
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Cushing's syndromes (CS) due to thymic carcinoids are rarely seen. In this text, a case with CS due to ectopic adrenocorticotropic hormone (ACTH) secreting atypical thymic carcinoid tumor is presented. A 50-year-old Turkish male patient was admitted to our emergency department with typical CS features. Basal hormone profile, low- and high-dose dexamethasone suppression tests, and inferior petrosal sinus sampling results were consistent with ectopic ACTH secretion. Thorax computerized tomography showed an upper mediastinal mass, and trans-thoracic biopsy showed atypical thymic carcinoid with positive ACTH staining. Since the vascular invasion was detected, tumor was accepted inoperable; somatostatine receptor analogs, chemotherapy, and radiotherapy were planned. Ectopic CS can be derived from atypical thymic carcinoid. In this case, ACTH staining was used to confirm ACTH secretion from thymic tissue, and positive staining was detected. ACTH staining routinely was not performed for extra hypophyseal tissue tumors. In suspicious and difficult cases, ACTH staining can be helpful to confirm the presence of ACTH in tumor tissues.

Citing Articles

Case report: A challenging case of severe Cushing's syndrome in the course of metastatic thymic neuroendocrine carcinoma with a synchronous adrenal tumor.

Dzialach L, Wojciechowska-Luzniak A, Maksymowicz M, Witek P Front Endocrinol (Lausanne). 2024; 15:1399930.

PMID: 38948516 PMC: 11211248. DOI: 10.3389/fendo.2024.1399930.


Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Guerrero-Perez F, Peiro I, Marengo A, Teule A, Ruffinelli J, Llatjos R Rev Endocr Metab Disord. 2021; 22(4):1041-1056.

PMID: 33961211 DOI: 10.1007/s11154-021-09660-2.

References
1.
Moran C, Suster S . Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol. 2000; 114(1):100-10. DOI: 10.1309/3PDN-PMT5-EQTM-H0CD. View

2.
Modlin I, Lye K, Kidd M . A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97(4):934-59. DOI: 10.1002/cncr.11105. View

3.
Tiffet O, Nicholson A, Ladas G, Sheppard M, Goldstraw P . A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest. 2003; 124(1):141-6. DOI: 10.1378/chest.124.1.141. View

4.
Hofland L . Responsiveness to somatostatin analog treatment and potentials of novel somatostatin analog. J Endocrinol Invest. 2004; 26(8 Suppl):8-13. View

5.
Meinardi J, van den Berg G, Wolffenbuttel B, Kema I, Dullaart R . Cyclical Cushing's syndrome due to an atypical thymic carcinoid. Neth J Med. 2006; 64(1):23-7. View